Experience with femoro-popliteal vein as a conduit for vascular reconstruction in infected fields  by Gibbons, C.P. et al.
Experience with Femoro-Popliteal Vein as a Conduit for
Vascular Reconstruction in Infected Fields
C. P. Gibbons, C. J. Ferguson, L. J. Fligelstone and K. Edwards
Department of Vascular Surgery, Morriston Hospital, Swansea, U.K.
Objective: to review the outcome of femoro-popliteal vein grafts for arterial reconstruction in the presence of sepsis.
Patients and Methods: twenty-six patients underwent 27 arterial reconstructions with femoro-popliteal vein in the
presence of infection. Five had mycotic aneurysms (3 aortic, 1 iliac and 1 femoral), 21 had prosthetic graft infections
(9 aortic, 8 femoro-femoral, 2 axillo-femoral, 1 ilio-femoral and 1 femoral dacron patch) and one underwent superior
mesenteric artery reconstruction following ischaemic small bowel perforation.
Arterial reconstruction followed debridement of infected tissue, removing any infected graft, povidone iodine washout
and appropriate antibiotic cover. Where possible, new grafts were placed in a clean field or wrapped in omentum. Four
femoral anastomoses were covered by rectus femoris flaps.
Results: there was one early postoperative death (4%) and no limb loss. All others remained free from infection with patent
grafts at 1 month to 5 years (median 22 months). Three major wound infections healed without exposing the graft. One
infarcted rectus femoris flap required removal. Donor limb swelling was transient. Five required percutaneous angioplasty
and one underwent open profundaplasty within 3 months.
Conclusion: femoro-popliteal vein reconstruction with debridement and appropriate antibiotic therapy is recommended for
the treatment of arterial or graft infections.
Key Words: Mycotic aneurysm; Prosthetic graft infection; Femoro-popliteal vein; Arterial reconstruction.
Introduction
The standard treatment of arterial or prosthetic graft
infection has been by excision and debridement
followed by reconstruction using either in situ or
extra-anatomical prosthetic bypass.1,2 However, the
outcome is frequently unsatisfactory due to a high
rate of limb loss, unacceptable mortality and failure
to eliminate infection.3,4 More recently, encourag-
ing results have been obtained by Claggett,5±7
Nevelsteen8,9 and others10±13 using femoro-popliteal
veins for replacement of infected aortic grafts. We
have extended their use to arterial reconstruction
following other graft infections, mycotic aneurysms
of the aorto-iliac and common femoral vessels and
to visceral arterial bypass in grossly contaminated
fields. The outcome of 27 such cases is described
here, extending a previous preliminary report from
our unit.14
Patients and Methods
Twenty-six patients (20 men, 6 women; mean age 67,
range 56±89 years) underwent 27 arterial reconstruc-
tions with femoro-popliteal vein (SFPV) in the
presence of infection over a five-year period from
1997±2002 (Table 1).
Graft infections
Twenty-one prosthetic graft infections occurred
between 10 days and 28 years (median 27, mean 42
months) after the original surgery. Two patients pre-
sented acutely with frank haemorrhage from a fem-
oral anastomosis and another with an exposed
prosthetic graft in the groin. Three presented with
rapidly expanding femoral false aneurysms with pus
or slime around and unincorporated graft. In the
other patients the diagnosis of graft infection was
made by the presence of perigraft fluid and/or gas
on preoperative ultrasound or computerised axial
tomography (CT), preoperative aspiration or the dis-
covery of pus around the graft and the absence of graft
incorporation at surgery.
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Cultures grew a coliform in 7 cases, Staphylococcus
aureus, serratia and vancomycin-resistant Enterococ-
cus in one case each but in 11 patients (52%) no organ-
ism was grown despite the presence of frank pus for a
biofilm around the graft and absence of graft incorp-
oration at surgery.
Superficial femoral vein replacement of infected
prosthetic grafts was performed as soon as possible
after the diagnosis was made. However, one patient
early in the series had suffered reinfection 1 month
after an in situ prosthetic femoro-femoral replacement
graft for a previous graft infection and a further patient
had undergone multiple procedures for an infected
aorto-bifemoral graft over 28 years at another hospital.
Nine patients had infected aortic grafts: 3 aorto-iliac
and 6 aorto-femoral. There were 12 other graft infec-
tions: 2 axillo-bifemoral, 8 femoro-femoral, 1 ilio-
femoral crossover and 1 infected common femoral
dacron patch with a local false aneurysm.
Mycotic aneurysms
Five patients presented with mycotic aneurysms: 3
involving the infrarenal aorta, 1 the external iliac and
1 the common femoral artery bifurcation. The diagno-
sis of mycotic aneurysm was made by the clinical
presentation (high fever, pulsatile mass, pain and
leucocytosis) and typical radiographic appearances:
A loss of the normal arterial wall with perivascular
inflammatory thickening on CT scan, and a localised
saccular aneurysm on digital subtraction angiography
(DSA). Preoperative blood cultures were positive in 3
of these cases whereas cultures from the perivascular
pus confirmed the infective organism in the remaining
2. The organisms responsible were S. aureus in 3
(including 1 methicillin-resistant strain) and strepto-
cocci in 2. Two of the three cases with S. aureus had
hospital-acquired infections, from peripheral lines
and a central venous dialysis catheter, respectively.
All 3 patients with S. aureus infections had metastatic
abscesses elsewhere. In 2 patients the source of the
arterial infection was not clear. The remaining patient
had an infected iliac false aneurysm, which filled most
of the pelvis, following an attempted direct repair of
the external iliac artery during surgery at another
hospital for a colo-uretero-external iliac artery fistula
after radiotherapy and cystectomy.
Other patients
The remaining patient in this series, a 62 year old man,
presented with severe weight loss and mesenteric
angina. Whilst undergoing investigations, which had
shown a short superior mesenteric artery occlusion, he
developed faecal peritonitis, resulting from several
punctate small bowel ischaemic perforations. Small
bowel resection with a double-barrelled ileostomy
and peritoneal washout was combined with an infra-
renal aorto-superior mesenteric graft using SFPV. A
pelvic abscess was later drained under radiological
control prior to closure of the ileostomy at 8 weeks.
This patient, who had no usable long saphenous vein,
developed acute lower limb ischaemia and underwent
femoro-popliteal bypass using PTFE, which later
occluded and was replaced by SFPV. This in turn
thrombosed at 3 months due to a common femoral
artery stenosis, necessitating a dacron common fem-
oral patch. The dacron patch subsequently became
infected and required complete replacement of the
common femoral artery bifurcation by SFPV (included
above under graft infections).
Preoperative investigation
All patients underwent preoperative DSA except
those undergoing emergency surgery for bleeding.
CT scans were performed routinely for mycotic aneur-
ysms or infected grafts in the aorto-iliac segment.
Ultrasound was used for detection of pus around
extra-anatomical grafts. Whenever possible, duplex
Doppler was used to scan the femoro-popliteal veins
preoperatively. In this way 2 patients were found to
have an unsuitable vein on one side probably as a
result of previous deep vein thrombosis.
Antibiotic cover
All patients were given multiple antibiotics on induc-
tion to include cover for any organism cultured pre-
operatively. In most cases the antibiotics included
teicoplenin, co-amoxyclav, ciprofloxacillin and metro-
nidazole. Full antibiotic therapy was continued for
at least 1 week followed by a single specific antibiotic
for a further 5 weeks. In the 2 patients undergoing
partial prosthetic graft replacement no organism was
grown from the excised graft or surrounding pus but
low dose co-amoxyclav was continued for 12 months
in one and for 3 months in the other.
Operative technique
All operations were performed under general anaes-
thesia. Both legs were prepared in addition to the
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appropriate area of exposure for the bypass proce-
dure. Except in the two cases with active anastomotic
haemorrhage, the superficial femoral vein was har-
vested prior to exposure of the infected area, dissect-
ing it from below the profunda femoris vein to the
knee joint and `` ligaclipping'' the branches. More than
30 cm of vein graft is usually attainable by this
method. For aorto-femoral or axillo-femoral recon-
struction, complete lengths from both legs are
required whereas in other cases, including aorto-iliac
reconstruction, a single vein suffices. Two operative
teams are a great advantage, allowing either the sim-
ultaneous preparation of two veins or the infected
area to be exposed whilst a single vein is prepared.
Where possible, arterial control was obtained before
entering the infected field. The pus was then drained,
any infected graft excised and a thorough debride-
ment of the infected tissue was performed with
repeated washouts using, alternately, povidone iodine
and hydrogen peroxide. The new bypass was then
constructed using SFPV (Table 1). The individual
graft configuration was determined pragmatically,
depending on the individual situation and the
available vein. For bifurcated grafts (e.g. aorto-
bifemoral, aorto-iliac and common femoral) an
inverted Y configuration was constructed by anasto-
mosing a second length of vein end-to-side, (Fig. 1)
except in 2 patients where a femoro-femoral graft
was anastomosed to the femoral hood of an aorto-
profunda femoris graft (Fig. 2). In 2 patients a single
infected limb of an aorto-bifemoral graft was replaced
by SFPV. Both of these patients had a false femoral
aneurysm with surrounding pus around one limb of
the graft with reasonable tissue incorporation of the
body of the graft. Moreover, in one of these only one
femoral vein was usable so that full graft replacement
would not have been feasible even if it were deemed
necessary. Grafts were used in the reversed configur-
ation in most cases but antegrade valve-disrupted
veins were used in 3 cases early in the series, one of
which was a bifurcated vein for an aorto-iliac recon-
struction. Where disparity in diameter existed (e.g. for
end to end aortic anastomoses) the vein was fish-
mouthed prior to anastomosis to avoid inappropriate
angulation, which occurred in early cases where a spa-
tulated vein had been used. Continuous polypropylene
sutures (4/0 or 5/0) were used for all anastomoses.
The new graft was, whenever feasible, placed in a
fresh tunnel and intraperitoneal grafts were wrapped
in omentum. In 1 case an iliac-superficial femoral graft
was run under the inguinal ligament lateral to the
femoral nerve and under the cover of sartorius to
separate it from any residual infected tissue after
removal of a mycotic femoral aneurysm. (This proved
advantageous as a subsequent wound breakdown
failed to expose the graft) (Fig. 3). All anastomoses
were covered by gentamicin-impregnated collagen
foam (or, in one early case, gentamicin beads) prior
to closure with multiple suction drains.
Fig. 1. Inverted Y configuration of SFPV reconstruction for aorto-
iliac replacement. In this patient the left limb of the graft was
inserted into the common femoral artery and the right limb into
the common iliac artery (overlaid by the right ureter).
Fig. 2. Composite reconstruction of an intra-arterial DSA of the
SFPV replacement of aorto-bifemoral graft by aorto-right femoral 
right to left femoro-femoral graft. The rather ectatic femoral anasto-
moses have remained unchanged 4 years postoperatively.
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Adjunctive procedures
In 4 patients where the previous groin anastomosis
had been exposed, the overlying tissue was thin or
when there appeared to be a high risk of wound
breakdown (due to gross infection or tissue necrosis)
a rectus femoris muscle flap was used to cover the
femoral anastomosis (Fig. 4).
Two patients underwent simultaneous distal grafts:
one femoro-popliteal graft using reversed long saphe-
nous vein and one femoro-posterior tibial graft using
arm veins.
Postoperative follow-up
Clinical follow-up and duplex Doppler graft sur-
veillance was performed at 6 weeks, then 3 monthly
for 1 year, 6 monthly for a further 2 years and yearly
thereafter.
Results
Following 27 procedures on 26 patients, there was
only 1 postoperative death (4%), which occurred at
2 h due to myocardial infarction. Of the remaining
25, 24 patients are alive without major amputation at 1
month to 5 years (median 22, mean 23 months) but
one 89 year old patient with an ilio-femoral graft died
at six months with an acute aortic thrombosis shortly
after a myocardial infarct. One patient defaulted from
follow-up after 1 month but was reported by his gen-
eral practitioner to be alive with both limbs intact at 12
months. All other patients are known to have patent
grafts at the time of writing.
Postoperative length of stay in the survivors ranged
from 12 to 124 days (median 23 days). Early complica-
tions included wound breakdown due to infection in 3
patients but in no case did the graft become exposed.
Of the 4 wounds in which a rectus femoris flap was
involved, three healed uneventfully but in one case
the muscle flap and upper sartorius underwent necro-
sis, but the wound healed primarily after excision of
the necrotic muscle and resuture of the wound. Four
patients developed significant seromas in the thigh
following deep vein excision, requiring open drainage
Fig. 4. The use of a rectus femoris muscle flap to cover femoral
anastomosis after SFPV reconstruction: (a) the mobilised muscle;
(b) the rectus femoris flap overlying the anastomosis.
Fig. 3. Intra-arterial DSA of iliac-superficial femoral bypass graft for
common femoral mycotic aneurysm using SFPV, demonstrating the
lateral course under the inguinal ligament to avoid the infected area.
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in 2. One patient, who underwent replacement of an
infected aorto-bifemoral graft with femoral vein,
developed a left ureteric leak, which was successfully
treated percutaneously by a ureteric stent and a tem-
porary nephrostomy four days postoperatively. A fur-
ther patient underwent laparotomy and division of
adhesions at 3 weeks for small bowel obstruction.
There was 1 deep vein thrombosis within the leg
that had not been used for deep vein harvesting and
the patient with an infected false aneurysm of the
external iliac artery had a concomitant iliac vein
thrombosis on that side. One patient developed recur-
rent pulmonary emboli at 8 weeks following surgery.
Leg oedema occurred in all limbs from which femoro-
popliteal veins had been harvested ranging from mild
to moderately severe but resolved or improved mark-
edly in all cases within 3 months. One patient devel-
oped mild lipodermatosclerosis at 1 year.
Five patients developed significant anastomotic ste-
noses detected by duplex surveillance after 6 weeks.
One was at the aortic anastomosis, 3 occurred at the
anastomosis between the graft and the femoral artery
and 1 at the inflow just proximal to a femoro-femoral
graft. Four were successfully treated by percutaneous
angioplasty (PTA) within 3 months although one of
these required a repeat procedure to a graft±profunda
femoris anastomosis at 7 months. The fifth patient
underwent open profundaplasty at 4 weeks, then a
PTA to a stenosis distal to the vein±vein anastomosis
of an aorto-bifemoral graft at 3 months, followed by a
stent insertion when the latter venous stenosis
recurred at 4 months.
The patient who underwent an infrarenal aorto-
superior mesenteric graft remains well with a patent
graft and free from intestinal angina at 30 months
despite having a pelvic abscess drained at 1 month
and suffering from candida septicaemia.
Discussion
This study confirms that femoro-popliteal veins are
useful as autologous grafts for arterial reconstruction
in infected fields. This confirms the work of Claggett,5±7
Nevelsteen8,9 and others10±13 on infected aortic grafts
and extends the results of our previous report,14 All 12
aortic reconstructions in the present report were suc-
cessful despite the magnitude of the surgery involved.
In addition, we have also found SFPV grafts useful
in other infected areas including mycotic aneurysms,
infected femoro-femoral, ilio-femoral and axillo-
femoral grafts and for intra-abdominal arterial recon-
struction in the presence of peritonitis. In these
situations SFPV may be preferable to long saphenous
vein because of its greater calibre and possibly also
because its thicker wall may be more resistant to
infection.
The use of autologous tissue is important to prevent
reinfection, which occurs in up to 23% of the cases
where in situ or extra-anatomic prosthetic reconstruc-
tion is used.3 A successful outcome also depends on
the prompt eradication of infection by appropriate
antibiotic therapy, a thorough debridement of infected
and necrotic material and antiseptic washouts. It is
also important to anastomose the new autologous
graft to clean uninfected artery and to separate the
new graft from the infected area by placing it in a
fresh track whenever possible. In the abdomen an
omental wrap can be useful. The selective use of mus-
cle flaps such as the rectus femoris or gracilis7 may
help to prevent vein graft exposure and anastomotic
haemorrhage in the event of groin wound infection.
The rectus femoris flap is preferable to sartorius trans-
position in most cases, as it requires little extra time
when the incision for SFPV removal has already been
made, is almost bloodless in preparation and will
reach well above the inguinal ligament to cover the
distal anastomosis of femoro-femoral or axillo-femoral
grafts. In the patient where the rectus femoris flap
underwent necrosis the upper sartorius also infarcted
probably as a result of lateral circumflex femoral
artery thrombosis. However primary healing was
achieved after excision of the necrotic muscle.
The high mortality associated with vascular infec-
tions3,4 merits the use of multiple antibiotics to cover
all possible pathogens where the causative organism
is in doubt. When the causative organism has been
cultured preoperatively, antibiotic therapy may be
more focused but must be combined with routine
broad-spectrum prophylaxis. The routine addition
of a single dose of teicoplenin to peroperative
co-amoxyclav for all vascular procedures may be
responsible for the absence of MRSA prosthetic graft
infection in our unit despite a high incidence of MRSA
wound infection, in contrast to its increasing preva-
lence in other vascular units.4,15,16 In the case of vas-
cular and graft infections ciprofloxacin was usually
added to cover pseudomonas and also salmonella,
which is a common cause of mycotic aneurysms.2
Whereas all mycotic aneurysms grew pathogens,
only half of the patients meeting the criteria for graft
infection had positive cultures despite the absence of
graft incorporation and the presence of biofilm or
frank pus in all patients. Most patients had received
prior antibiotics but in one notable case with 400 ml of
perigraft pus at surgery repeated cultures prior to any
antibiotic therapy as well as perioperative cultures
failed to grow any pathogen. No specific techniques
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were used for cultures. Some of these patients had a
biofilm suggestive of staph epidermidis infection,
which may not have been cultured but the presence
of frank pus in most suggests the possibility of another
organism, which standard bacteriological methods
failed to isolate. The patients with biofilms and unin-
corporated grafts were those who presented with
rapidly expanding false aneurysms or frank bleeding
and required urgent surgery for preservation of life
or limb.
The original fears that lower limb oedema after
deep vein harvesting would be prohibitive have not
been realised in practice. Whilst some degree of tran-
sient oedema occurs in most cases, this is rarely
severe. In the longer term, there has been little clinical
evidence of venous insufficiency although ambulatory
venous pressures and venous refilling times are
abnormal.17 However, it is almost certainly important
to preserve the profunda femoris vein and to avoid
deep vein harvesting below the knee to prevent this
complication.18 Preservation of the LSV does not
appear to be of consequence.19 The occurrence of two
cases of thromboembolism in this series is not surpris-
ing in view of the magnitude of the surgery involved
and probably bares no relationship to the deep vein
harvesting per se.
Graft stenoses occurred in 5/27 (19%) reconstruc-
tions, which is a similar incidence to that occurring in
other vein grafts. All but one were anastomotic ste-
noses and were detected at the first surveillance. It
would seem likely that these occurred as a result of
intimal hyperplasia although the profunda stenosis,
which was corrected by open profundaplasty,
had probably been underestimated at the original
operation.
The low mortality and consistent limb preservation
in our series contrasts with the frequently disappoint-
ing results using either extra-anatomic or in situ pros-
thetic reconstruction3 but is generally in keeping with
others who have used the femoral vein in infected
fields.5±13 In situ reconstruction using rifampicin
bonded prosthetic grafts has been advocated for low-
grade gram-positive graft infections.20 However, is
unlikely to succeed in gram-negative infections or
when gross contamination exists and leaves the threat
of late reinfection. Silver impregnated grafts have also
been marketed for in situ reconstruction in infected
fields but insufficient data exists to evaluate their use.
Cryopreserved arterial allografts have proved disap-
pointing because of late aneurysmal degeneration and
the occurrence of late graft ruptures.21 The absence
from our series of aorto-enteric fistulae, which have a
much greater mortality and morbidity,3,22 has been
fortunate. This may be due in part to early radical
intervention whenever aortic graft infection was diag-
nosed rather than embarking on prolonged antibiotic
therapy and repeated attempts at conservative surgery.
The growing emergence of bacterial antibiotic
resistance is likely to increase the incidence of infec-
tive complications in arterial surgery and there is some
suggestion in our unit that this may already be occur-
ring. The high failure rates of standard techniques for
dealing with arterial or graft infections have hitherto
caused surgical pessimism in these situations. The
timely use of the femoro-popliteal vein has undoubt-
edly helped transform the previously dismal outlook
for these patients and, provided that all adjunctive
measures are taken to ensure that sepsis is eliminated
at the first attempt, a successful outcome can be
expected in the vast majority of cases.
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